Hans Thorleif Moller

Founder at Ranger Biotechnologies A/S

Non-Energy Minerals

Commercial Services

Health Technology

Profile

Hans Thorleif Moller is the founder.
He founded Profylakse ApS in 1999.
He also founded Ranger Biotechnologies A in 2009, where he currently holds the title of Chief Executive Officer & Director.
In addition to his founding positions, Dr. Moller has worked as a Principal at CEM Innovation A.

Hans Thorleif Moller active positions

Companies	Position	Start
Ranger Biotechnologies A/S Ranger Biotechnologies A/S Miscellaneous Commercial ServicesCommercial Services Mirrx Therapeutics A/S provides protein production technology. Its technology Blockmirs, is steric antisense blockers that bind to specific microRNA binding sites in target RNAs to thereby prevent microRNA binding to the same site. The company was founded by Hans Thorleif Møller on July 1, 2009 and is headquartered in Vejle, Denmark.	Founder	30/06/2009

All active positions of Hans Thorleif Moller

Former positions of Hans Thorleif Moller

Companies	Position	End
CEM Innovation A/S CEM Innovation A/S Construction MaterialsNon-Energy Minerals CEM Innovation A/S develops and supplies cement products. The firm's products are used in the engineering, construction, and other industries. The company is headquartered in Sonderso, Denmark.	Corporate Officer/Principal	17/03/2011
Profylakse ApS Profylakse ApS Pharmaceuticals: MajorHealth Technology Profylakse is a Danish biotech company, founded in 1999 by scientists from University of Southern Denmark. Profylakse has an experienced development team, working within microbiology, immunology and protein chemistry for 3 decades. Its focus is on the development of antiviral, not vaccines, especially against influenza and parainfluenza viruses. This has resulted in its antiviral recombinant SAP. Profylakse´s investor base is the Danish Technological Institute and the South Danish Innovations.	Founder	-

See the detail of Hans Thorleif Moller's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Hans Thorleif Moller's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	3
CEM Innovation A/S CEM Innovation A/S Construction MaterialsNon-Energy Minerals CEM Innovation A/S develops and supplies cement products. The firm's products are used in the engineering, construction, and other industries. The company is headquartered in Sonderso, Denmark.	Non-Energy Minerals
Ranger Biotechnologies A/S Ranger Biotechnologies A/S Miscellaneous Commercial ServicesCommercial Services Mirrx Therapeutics A/S provides protein production technology. Its technology Blockmirs, is steric antisense blockers that bind to specific microRNA binding sites in target RNAs to thereby prevent microRNA binding to the same site. The company was founded by Hans Thorleif Møller on July 1, 2009 and is headquartered in Vejle, Denmark.	Commercial Services
Profylakse ApS Profylakse ApS Pharmaceuticals: MajorHealth Technology Profylakse is a Danish biotech company, founded in 1999 by scientists from University of Southern Denmark. Profylakse has an experienced development team, working within microbiology, immunology and protein chemistry for 3 decades. Its focus is on the development of antiviral, not vaccines, especially against influenza and parainfluenza viruses. This has resulted in its antiviral recombinant SAP. Profylakse´s investor base is the Danish Technological Institute and the South Danish Innovations.	Health Technology

See company connections